FDA Approves First Blood Test to Diagnose Alzheimer's Disease
(Bloomberg) -- US regulators have approved the first blood test to help diagnose Alzheimer's disease, potentially making it easier to find and treat patients with the mind-robbing disease that affects nearly 7 million Americans.
The test made by Fujirebio Diagnostics Inc., a unit of Japan's H.U. Group Holdings Inc., was cleared for people 55 years and older who exhibit signs and symptoms of the disease, the US Food and Drug Administration said in a statement. It is designed for the early detection of amyloid, a protein that can build up in the brain and is a hallmark of Alzheimer's, the most common form of dementia in the elderly.
The development and approval of blood tests that can spot which patients are likely to have toxic amyloid in their brains has been viewed as a critical step toward making drugs to treat the condition more widely accessible. While the test is approved for people who are already exhibiting signs of cognitive impairment, studies show amyloid begins accumulating in the brains of some patients years before symptoms begin.
To qualify for drug treatment, patients now generally get a specialized PET scan to detect amyloid in their brains or undergo a cerebrospinal fluid test. The PET scans are expensive and require specialized equipment, while the spinal fluid tests involve an invasive procedure.
The need for these tests has slowed the rollout of new Alzheimer's drugs like Leqembi from Eisai Co. and Biogen Inc., and Eli Lilly & Co.'s Kisunla.
Fujirebio's newly approved test, called Lumipulse, only requires a blood draw, making it less invasive and potentially easier for patients to access. It's unclear how much it will cost or when it will be available. It's intended for patients at a specialized care setting who are experiencing cognitive decline, according to the FDA.
The blood test shouldn't be used alone to diagnose the disease, in part because of the risk of false positive or negative results, the agency said. Other clinical evaluations and additional tests should be used to determine treatment options, it said.
More stories like this are available on bloomberg.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
3 hours ago
- India Today
Dementia, Alzheimer's or just brain fog? Here's how to tell the difference
For years, conditions like dementia and Alzheimer's disease were often brushed aside in India as issues of "old age" or even mistaken for personality with rising awareness and better healthcare access, families and doctors are starting to recognise these as medical concerns reported closer to home that deserve timely to the Alzheimer's and Related Disorders Society of India (ARDSI), more than 5.3 million Indians are currently living with dementia, and this number is expected to triple by 2050 due to the country's ageing DEMENTIA VS ALZHEIMER'S: WHAT'S THE DIFFERENCE?While people often use the terms interchangeably, dementia and Alzheimer's disease are not the same is an umbrella term, used to describe a group of symptoms that affect memory, thinking, and social abilities severely enough to interfere with daily life. It happens when cells in the brain slowly begin to die. In dementia, symptoms can include forgetfulness, confusion, having trouble speaking, having difficulty in comprehending conversations, pulling away, and change in is the most common type of dementia, accounting for 60% to 70% of all dementia cases in the of dementia as the disease and Alzheimer's as one of the main are other forms of dementia too, like vascular dementia, frontotemporal dementia, and Lewy body dementia. Each has different causes and Alzheimer's disease, the brain undergoes physical changes, including the build-up of abnormal proteins that slowly damage and kill brain leads to progressive memory loss, confusion, and changes in personality and dementia can strike in the 60s and above, symptoms are now striking as young as the 40s, known as young-onset DOES BRAIN FOG FIT IN?Unlike dementia and Alzheimer's, brain fog is not a medical diagnosis, but a term people use to describe a temporary state of mental cloudiness. Think of dementia as the disease and Alzheimer's as one of the main causes. () It can feel like difficulty concentrating, forgetfulness, or struggling to find words. Brain fog can be triggered by stress, lack of sleep, hormonal changes, or illness, including the after Covid-19 effects or long fog is usually reversible but dementia is not since it is a brain-shrinking disease. Brain fog can mimic some symptoms of dementia, like confusion, forgetting instructions of something you're can also happen because of an illness or a side effect of medication or a symptom of an underlying condition, according to Cleveland fog feels like difficulty concentrating, confusion, fatigue, forgetfulness, losing your train of thought, mental exhaustion, not having the right words, slow thought process and reaction time and trouble paying attention. Brain fog is usually reversible but dementia is not since it is a brain-shrinking disease. () In some cases, many lifestyle factors can trigger brain fog, signalling brain tumors, which may initially manifest with subtle cognitive DIAGNOSIS CAN MAKE A DIFFERENCEWhile there is no cure for dementia or Alzheimer's, early diagnosis can help slow progression and improve quality of sooner it is detected, the better it can be managed, whether through medication, lifestyle changes, or caregiver signs like frequently forgetting appointments, misplacing objects, repeating questions, or withdrawing from social activities should not be ignored, especially if they worsen over brain fog, though milder, can still be disruptive. Treating it often means improving sleep, managing stress, and correcting nutritional deficiencies (vitamin D or B12). If it persists, a medical evaluation can rule out more serious Watch
Time of India
3 hours ago
- Time of India
NIH scientists go public to criticize Trump's deep cuts in public health research
Cardboard tombstones symbolizing canceled research grants at the NIH Visitors Center in Bethesda (AP) WASHINGTON: In his confirmation hearings to lead the National Institutes of Health, Jay Bhattacharya pledged his openness to views that might conflict with his own. "Dissent, he said, "is the very essence of science. " That commitment is being put to the test. On Monday, scores of scientists at the agency sent their Trump-appointed leader a letter titled the Bethesda Declaration, a frontal challenge to "policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe." It says: "We dissent." In a capital where insiders often insist on anonymity to say such things publicly, more than 90 NIH researchers, program directors, branch chiefs and scientific review officers put their signatures on the letter - and their careers on the line. Confronting a 'culture of fear' They went public in the face of a "culture of fear and suppression" they say President Donald Trump 's administration has spread through the federal civil service. "We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources," the declaration says. Named for the agency's headquarters location in Maryland, the Bethesda Declaration details upheaval in the world's premier public health research institution over the course of mere months. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo It addresses the abrupt termination of 2,100 research grants valued at more than $12 billion and some of the human costs that have resulted, such as cutting off medication regimens to participants in clinical trials or leaving them with unmonitored device implants. In one case, an NIH-supported study of multi-drug-resistant tuberculosis in Haiti had to be stopped, ceasing antibiotic treatment mid-course for patients. In a number of cases, trials that were mostly completed were rendered useless without the money to finish and analyze the work, the letter says. "Ending a $5 million research study when it is 80% complete does not save $1 million," it says, "it wastes $4 million." The mask comes off The four-page letter, addressed to Bhattacharya but also sent to Health Secretary Robert F. Kennedy Jr. and members of Congress who oversee the NIH, was endorsed by 250 anonymous employees of the agency besides the 92 who signed. Jenna Norton, who oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases, recently appeared at a forum by Sen. Angela Alsobrooks, D-Md., to talk about what's happening at the NIH. At the event, she masked to conceal her identity. Now the mask is off. She was a lead organizer of the declaration. "I want people to know how bad things are at NIH," Norton told The Associated Press. The signers said they modeled their indictment after Bhattacharya's own Great Barrington Declaration of October 2020, when he was a professor at Stanford University Medical School. His declaration drew together likeminded infectious disease epidemiologists and public health scientists who dissented from what they saw as excessive COVID-19 lockdown policies and felt ostracized by the larger public health community that pushed those policies, including the NIH. "He is proud of his statement, and we are proud of ours," said Sarah Kobrin, a branch chief at the NIH's National Cancer Institute who signed the Bethesda Declaration. Cancer research is sidelined As chief of the Health Systems and Interventions Research Branch, Kobrin provides scientific oversight of researchers across the country who've been funded by the cancer institute or want to be. But sudden cuts in personnel and money have shifted her work from improving cancer care research to what she sees as minimizing its destruction. "So much of it is gone - my work," she said. The 21-year NIH veteran said she signed because "I don't want to be a collaborator" in the political manipulation of biomedical science. Ian Morgan, a postdoctoral fellow with the National Institute of General Medical Sciences, also signed the declaration. "We have a saying in basic science," he said. "You go and become a physician if you want to treat thousands of patients. You go and become a researcher if you want to save billions of patients. "We are doing the research that is going to go and create the cures of the future," he added. But that won't happen, he said, if Trump's Republican administration prevails with its searing cuts to grants. The NIH employees interviewed by the AP emphasized they were speaking for themselves and not for their institutes or the NIH. Dissenters range across the breadth of NIH Employees from all 27 NIH institutes and centers gave their support to the declaration. Most who signed are intimately involved with evaluating and overseeing extramural research grants. The letter asserts that "NIH trials are being halted without regard to participant safety" and that the agency is shirking commitments to trial participants who "braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health." The Trump administration has gone at public health research on several fronts, both directly, as part of its broad effort to root out diversity, equity and inclusion values throughout the bureaucracy, and as part of its drive to starve some universities of federal money. A blunt ax swings This has forced "indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science," the declaration says. Some NIH employees have previously come forward in televised protests to air grievances, and many walked out of Bhattacharya's town hall with staff. The declaration is the first cohesive effort to register agency-wide dismay with the NIH's direction. A Signal group became the place for participants to sort through NIH chatter on Reddit, discern rumor from reality and offer mutual support. The declaration took shape in that group and as word spread neighbor to neighbor in NIH offices. The dissenters remind Bhattacharya in their letter of his oft-stated ethic that academic freedom must be a lynchpin in science. With that in place, he said in a statement in April, "NIH scientists can be certain they are afforded the ability to engage in open, academic discourse as part of their official duties and in their personal capacities without risk of official interference, professional disadvantage or workplace retaliation." Now it will be seen whether that's enough to protect those NIH employees challenging the Trump administration and him. "There's a book I read to my kids, and it talks about how you can't be brave if you're not scared," said Norton, who has three young children. "I am so scared about doing this, but I am trying to be brave for my kids because it's only going to get harder to speak up. "Maybe I'm putting my kids at risk by doing this," she added. "And I'm doing it anyway because I couldn't live with myself otherwise."
Hindustan Times
11 hours ago
- Hindustan Times
Gastroenterologist says ‘more fibre means better weight control'; shares best supplement for irritable bowel syndrome
Dr Saurabh Sethi, a California-based gastroenterologist trained at AIIMS, Harvard, and Stanford Universities, often shares health and nutritional tips on Instagram that people who suffer from gut or liver issues or those who want to strengthen their gut microbiome should follow. Also Read | AIIMS, Harvard gastroenterologist ranks 6 common foods for gut health: Fermented foods score highest In a video shared on June 4, Dr Sethi talked about the 6 things about gut health that he wishes 'more people knew'. He posted educational inputs on fibre, how it benefits our body and can also create problems, what is the best supplement for irritable bowel syndrome (IBS), and more. Here are the 6 tips he shared: A post shared by Saurabh Sethi (@ 1. Vegetables often have less fibre than fruits, nuts, beans, and seeds. 2. About 90 percent of Americans are fibre-deficient. This trend of insufficient fibre intake is common worldwide. 3. More fibre = better weight control, cholesterol, reflux, and gut health. 4. Soluble fibre helps calm diarrhoea; insoluble fibre helps with constipation. 5. Add fibre slowly - some gas and bloating at first is totally normal. Your gut bugs are just adjusting. 6. Psyllium is the best-studied fibre supplement, especially helpful for irritable bowel syndrome (IBS). Also Read | How to protect gut and liver health in your 20s, 30s, 40s, 50s and 60s? Gastroenterologist shares tips The question now arises, why is fibre considered an important supplement for our gut health? According to the Mayo Clinic, dietary fibre increases the weight and size of stool and softens it. In general, bulky stool is easier to pass, and this lowers the chance of constipation. If you have loose, watery stools, fibre may help make them solid. That's because fibre absorbs water and adds bulk to stool. Additionally, according to the National Institutes of Health (NIH), dietary fibre is fermented by the human gut microbiota, producing beneficial microbial metabolites, such as short-chain fatty acids. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
